KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Xenon Pharmaceuticals (XENE) Return on Assets: 2014-2025

Historic Return on Assets for Xenon Pharmaceuticals (XENE) over the last 11 years, with Sep 2025 value amounting to -0.50%.

  • Xenon Pharmaceuticals' Return on Assets fell 25.00% to -0.50% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.50%, marking a year-over-year decrease of 25.00%. This contributed to the annual value of -0.28% for FY2024, which is 7.00% down from last year.
  • Xenon Pharmaceuticals' Return on Assets amounted to -0.50% in Q3 2025, which was down 21.20% from -0.41% recorded in Q2 2025.
  • In the past 5 years, Xenon Pharmaceuticals' Return on Assets ranged from a high of -0.13% in Q2 2022 and a low of -0.50% during Q3 2025.
  • Over the past 3 years, Xenon Pharmaceuticals' median Return on Assets value was -0.25% (recorded in 2024), while the average stood at -0.29%.
  • Per our database at Business Quant, Xenon Pharmaceuticals' Return on Assets climbed by 10bps in 2022 and then fell by 25bps in 2025.
  • Xenon Pharmaceuticals' Return on Assets (Quarterly) stood at -0.19% in 2021, then grew by 2bps to -0.16% in 2022, then decreased by 6bps to -0.22% in 2023, then fell by 8bps to -0.30% in 2024, then dropped by 25bps to -0.50% in 2025.
  • Its Return on Assets was -0.50% in Q3 2025, compared to -0.41% in Q2 2025 and -0.34% in Q1 2025.